VAMP5
Basic information
Region (hg38): 2:85584431-85593406
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the VAMP5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 13 | 15 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 13 | 2 | 0 |
Variants in VAMP5
This is a list of pathogenic ClinVar variants found in the VAMP5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-85591775-A-T | not specified | Uncertain significance (Dec 22, 2023) | ||
2-85591776-A-C | not specified | Uncertain significance (Jul 13, 2021) | ||
2-85591781-G-C | not specified | Uncertain significance (Oct 24, 2023) | ||
2-85591782-C-T | not specified | Uncertain significance (Jan 24, 2024) | ||
2-85591815-G-A | not specified | Uncertain significance (Aug 11, 2022) | ||
2-85592989-G-C | not specified | Uncertain significance (Dec 13, 2023) | ||
2-85593009-G-A | not specified | Uncertain significance (Feb 17, 2022) | ||
2-85593015-G-A | not specified | Uncertain significance (Nov 17, 2022) | ||
2-85593023-G-A | not specified | Uncertain significance (Mar 11, 2024) | ||
2-85593029-C-A | not specified | Uncertain significance (Dec 26, 2023) | ||
2-85593077-G-A | not specified | Likely benign (Jan 10, 2022) | ||
2-85593110-G-A | not specified | Uncertain significance (Dec 14, 2023) | ||
2-85593116-C-T | not specified | Uncertain significance (Sep 14, 2021) | ||
2-85593117-G-A | not specified | Likely benign (Aug 02, 2023) | ||
2-85593129-C-T | not specified | Uncertain significance (Nov 27, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
VAMP5 | protein_coding | protein_coding | ENST00000306384 | 3 | 9005 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0111 | 0.642 | 125587 | 0 | 157 | 125744 | 0.000624 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0798 | 73 | 74.9 | 0.974 | 0.00000503 | 750 |
Missense in Polyphen | 22 | 29.386 | 0.74867 | 283 | ||
Synonymous | -0.650 | 34 | 29.5 | 1.15 | 0.00000175 | 243 |
Loss of Function | 0.430 | 3 | 3.92 | 0.766 | 1.67e-7 | 50 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000214 | 0.000213 |
Ashkenazi Jewish | 0.0122 | 0.0123 |
East Asian | 0.000217 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000202 | 0.000202 |
Middle Eastern | 0.000217 | 0.000217 |
South Asian | 0.00 | 0.00 |
Other | 0.000489 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: May participate in trafficking events that are associated with myogenesis, such as myoblast fusion and/or GLUT4 trafficking.;
- Pathway
- SNARE interactions in vesicular transport - Homo sapiens (human);Nicotine Pathway (Dopaminergic Neuron), Pharmacodynamics
(Consensus)
Recessive Scores
- pRec
- 0.0260
Intolerance Scores
- loftool
- 0.527
- rvis_EVS
- -0.14
- rvis_percentile_EVS
- 42.88
Haploinsufficiency Scores
- pHI
- 0.0106
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.478
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.281
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Vamp5
- Phenotype
- growth/size/body region phenotype; renal/urinary system phenotype; respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- muscle organ development;skeletal muscle tissue development;cell differentiation;Golgi to plasma membrane protein transport
- Cellular component
- late endosome;trans-Golgi network;plasma membrane;integral component of plasma membrane;cell surface;intercalated disc;cytoplasmic vesicle membrane;integral component of organelle membrane;perinuclear region of cytoplasm;extracellular exosome
- Molecular function
- protein binding